Three major Medicare policy wins were signed into law on February 4, 2026, as part of a $1.2 trillion federal funding package. The legislation extends critical telehealth flexibilities, preserves hospital-at-home programs, and enacts long-awaited pharmacy benefit manager (PBM) reforms.
Here's what Medicare beneficiaries need to know about each change.
📱 Telehealth Flexibilities Extended Through 2027
What changed: Medicare telehealth coverage expansions introduced during the COVID-19 pandemic have been extended for two more years through December 31, 2027.
What it means for you:
- Home visits still covered: You can continue receiving telehealth services at home, not just at designated medical facilities
- Audio-only visits: Phone-only appointments remain eligible for reimbursement (helpful for seniors without smartphones or internet)
- Broader provider access: Physical therapists, occupational therapists, and speech-language pathologists can continue providing remote care
- Geographic flexibility: Rural and urban beneficiaries have equal access to telehealth services
Why it matters: Without this extension, many telehealth services would have ended on December 31, 2025, forcing millions of seniors back to in-person appointments even when remote care is medically appropriate.
🏠 Hospital-at-Home Program Gets 5-Year Extension
What changed: The Medicare Acute Hospital Care at Home waiver program has been extended for five years, allowing hospitals to provide acute-level care in patients' homes.
What it means for you:
- Home-based acute care: Eligible patients can receive hospital-level monitoring, medications, and nursing care at home
- Lower infection risk: Avoid hospital-acquired infections by recovering at home
- Better sleep and comfort: Familiar environment with family support nearby
- Same Medicare coverage: Services billed as inpatient stays with typical Part A coverage rules
Who qualifies: Not all conditions are eligible. Common qualifying scenarios include pneumonia, heart failure, COPD exacerbations, and certain infections. Your doctor and hospital determine eligibility.
Availability: Over 300 hospitals across 37 states participate in the program. Availability varies by location.
💊 Pharmacy Benefit Manager (PBM) Reforms
What changed: New rules prohibit PBMs from tying their compensation to drug list prices and rebates in Medicare Part D plans — a practice known as "delinking."
The old system: PBMs negotiated rebates with drug manufacturers and kept a percentage. Higher list prices meant higher rebates and higher PBM profits, creating perverse incentives.
The new system: PBMs will be paid flat fees that reflect the fair market value of their services, not a percentage of drug costs.
What it means for you:
- Potential premium relief: Without rebate-chasing incentives, Part D premiums may stabilize or decrease
- Lower out-of-pocket costs: Reduced artificial inflation of list prices could lower copays and deductibles
- More transparency: Clearer understanding of actual drug costs without hidden rebate schemes
- Better drug access: PBMs have less incentive to favor high-rebate drugs over lower-cost alternatives
Timeline: Implementation details and effective dates are still being finalized by CMS. Expect gradual rollout over 2026-2027.
⚠️ What These Changes Don't Do
While these policies are significant wins for Medicare beneficiaries, they don't address:
- Medicare Advantage rate cuts: Separate issue; 2027 rates proposed at near-flat 0.9% increase
- Part B premium costs: Standard Part B premium ($185/month in 2026) not affected
- Drug shortages: PBM reform doesn't solve supply chain issues
- Long-term care coverage: Medicare still doesn't cover custodial nursing home care
What Seniors Should Do Now
- Ask about telehealth options: If you've been avoiding care due to travel difficulties, ask your doctor about telehealth availability for routine follow-ups.
- Inquire about hospital-at-home: If you live near a participating hospital and face an acute illness, ask whether you qualify for home-based care.
- Review Part D coverage: As PBM reforms roll out, watch for changes in your drug formulary or plan premiums. Compare options during the next enrollment period.
- Check provider participation: Not all doctors offer telehealth, and not all hospitals participate in hospital-at-home. Confirm availability in your area.
Political Context
These provisions passed with strong bipartisan support, reflecting widespread agreement on:
- Telehealth value: Both parties recognize remote care improved access during the pandemic and should continue
- PBM accountability: Years of criticism over opaque rebate schemes and inflated drug prices pushed Congress to act
- Home care preference: Studies show hospital-at-home programs reduce costs while maintaining quality
The funding package avoided controversial Medicare cuts, though separate battles over Medicare Advantage payment rates continue.
Looking Ahead
Telehealth beyond 2027: The two-year extension buys time for Congress to make permanent decisions about which telehealth services should remain covered long-term.
PBM enforcement: The devil is in the details. CMS will issue regulations defining "fair market value" for PBM compensation. Industry groups will push back on implementation.
Hospital-at-home expansion: With five years of certainty, expect more hospitals to invest in home care infrastructure and technology.
Bottom Line
These three policy changes represent rare good news for Medicare beneficiaries: expanded access to convenient care, protection of pandemic-era telehealth gains, and structural reforms to reduce drug costs.
While implementation details are still being worked out, the direction is clear: Medicare is adapting to support care in the home and increase transparency in drug pricing.
Stay informed: Check with your doctors and plans about how these changes affect your specific coverage. More guidance from CMS is expected throughout 2026.
Review Your Medicare Coverage
Use our free tools to compare plans and estimate costs.
Additional Resources
- Medicare & You Handbook - Official coverage guide
- Medicare Plan Finder - Compare Part D drug plans
- CMS Newsroom - Latest policy updates